Stock News•1 week ago
DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study
DexCom's G7 CGM improved A1C levels and glucose control in non-insulin Type 2 diabetes patients in the CONNECT study, supporting broader CGM adoption.
MarketLens
Why is AI Revolutionizing Diabetes Care Now
7 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
What is TurboGen and Why Should Investors Care
7 months ago
Category
You may also like
Stock News•3 weeks ago
Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency
HoneyNaps, an AI sleep-health technology company, is gaining adoption among pharmaceutical companies and research organizations for objective sleep data in clinical trials, per PRNewswire. The shift r...
Stock News•2 months ago
AI Is Reshaping Clinical Nutrition: Precision Therapy, Venture Capital, and the Food-as-Medicine Frontier
AI is transforming clinical nutrition across parenteral care, infant formula, and chronic disease management, per a new BCC Research Pulse Report. The report highlights AI-driven precision therapy and...
Breaking News
View All →Featured Articles
Top Headlines
Stock News•59 minutes ago
Jim Cramer sees major implications from SK Hynix's home-run quarter
Stock News•1 hour ago
Google parent Alphabet tumbles after profit disappoints, warns AI is battering its cash flow
Stock News•1 hour ago
Jim Cramer says these tech giants can weather market turbulence
Stock News•1 hour ago
Alphabet Inc. (GOOG) Misses Q3 Earnings and Revenue Estimates
Stock News•1 hour ago